AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS

Go back to AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS
Amgen Inc (NASDAQ: AMGN) Delayed: 344.72 +7.12 (2.11%)
Previous Close $337.60    52 Week High $176.85 
Open $337.65    52 Week Low $133.64 
Day High $345.11    P/E 51.92 
Day Low $337.60    EPS $6.64 
Volume 2,520,731